CVE-2018-6475
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking,...
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking, leading to Escalation of Privileges.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking, leading to Escalation of Privileges.
- Record
CVE-2018-6475- CVSS 3.0
- 7.8 High
CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - CVSS 2.0
- 9.3 High
AV:N/AC:M/Au:N/C:C/I:C/A:C - Weakness
- CWE-426
- Updated
- 2026-11-02
CVE List No score
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking, leading to Escalation of Privileges.
- Record
CVE-2018-6475- Updated
- 2026-11-02
EUVDEUVD-2018-18231 No score
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking, leading to Escalation of Privileges.
- Record
EUVD-2018-18231- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-4xwx-cf3j-hqr4
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking,...
In SUPERAntiSpyware Professional Trial 6.0.1254, SUPERAntiSpyware.exe allows DLL hijacking, leading to Escalation of Privileges.
- Record
GHSA-4xwx-cf3j-hqr4- CVSS 3.0
- 7.8 High
CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H - Weakness
- CWE-426
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2018-6475 is a high vulnerability (CVSS 7.8) in Superantispyware, published January 31, 2018. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.95%, the 61st percentile. No source names a fixed version.